Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Mandelblatt

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Cancer|July 23, 2016
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Jonathan D Clapp, Gheorghe Luta, et al.
Annals of Internal Medicine|November 19, 2009
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harmsJeanne S Mandelblatt, Kathleen A Cronin, Stephanie Bailey, et al.
Cancers|June 10, 2023
Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and ControlsKelly Nudelman, Kwangsik Nho, Michael Zhang, et al.
JNCI Cancer Spectrum|March 31, 2024
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer studyArthur Patrick McDeed, Kathleen Van Dyk, Xingtao Zhou, et al.
Research Square|April 21, 2021
Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer SurvivorsA Dilawari, K E Rentscher, W Zhai, et al.
Annals of Internal Medicine|August 23, 2016
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening OutcomesAmy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, et al.
Annals of Internal Medicine|July 16, 2014
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefitsIris Lansdorp-Vogelaar, Roman Gulati, Angela B Mariotto, et al.
Journal of the National Cancer Institute|July 29, 2021
Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-EffectivenessJennifer M Yeh, Kathryn P Lowry, Clyde B Schechter, et al.
Journal of the National Cancer Institute|May 30, 2014
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammographyNatasha K Stout, Sandra J Lee, Clyde B Schechter, et al.
Journal of the National Cancer Institute|September 27, 2014
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortalityDiego Munoz, Aimee M Near, Nicolien T van Ravesteyn, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Cancer|July 23, 2016
Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)Jeanne S Mandelblatt, Jonathan D Clapp, Gheorghe Luta, et al.
Annals of Internal Medicine|November 19, 2009
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harmsJeanne S Mandelblatt, Kathleen A Cronin, Stephanie Bailey, et al.
Cancers|June 10, 2023
Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and ControlsKelly Nudelman, Kwangsik Nho, Michael Zhang, et al.
JNCI Cancer Spectrum|March 31, 2024
Prediction of cognitive decline in older breast cancer survivors: the Thinking and Living with Cancer studyArthur Patrick McDeed, Kathleen Van Dyk, Xingtao Zhou, et al.
Research Square|April 21, 2021
Medical Care Disruptions During the First Six-Months of the COVID19 Pandemic: The Experience of Older Breast Cancer SurvivorsA Dilawari, K E Rentscher, W Zhai, et al.
Annals of Internal Medicine|August 23, 2016
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening OutcomesAmy Trentham-Dietz, Karla Kerlikowske, Natasha K Stout, et al.
Annals of Internal Medicine|July 16, 2014
Personalizing age of cancer screening cessation based on comorbid conditions: model estimates of harms and benefitsIris Lansdorp-Vogelaar, Roman Gulati, Angela B Mariotto, et al.
Journal of the National Cancer Institute|July 29, 2021
Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-EffectivenessJennifer M Yeh, Kathryn P Lowry, Clyde B Schechter, et al.
Journal of the National Cancer Institute|May 30, 2014
Benefits, harms, and costs for breast cancer screening after US implementation of digital mammographyNatasha K Stout, Sandra J Lee, Clyde B Schechter, et al.
Journal of the National Cancer Institute|September 27, 2014
Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortalityDiego Munoz, Aimee M Near, Nicolien T van Ravesteyn, et al.
Pageof 20